MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
ORKA Cash Flow Sankey DiagramSankey diagram visualizing ORKA cash flow for the periodProceeds from april 2026offering, net of offering...-$658,336K Proceeds from issuance ofcommon stock upon...$4,369K (3908.26%↑ Y/Y)Proceeds from issuance ofcommon stock under...$337K Net cash provided byfinancing activities$663,042K (608195.41%↑ Y/Y)Net increase in cashand cash...$218,950K (5630.18%↑ Y/Y)Canceled cashflow$444,092K Proceeds from maturitiesof marketable...$79,600K (-60.21%↓ Y/Y)Stock-based compensationexpense$7,284K (-26.87%↓ Y/Y)Accrued expenses andother current...$5,062K (2081.90%↑ Y/Y)Accounts payable$4,288K (256.74%↑ Y/Y)Non-cash lease expense$149K (-20.32%↓ Y/Y)Depreciation expense$43K (22.86%↑ Y/Y)Net cash (used in)provided by investing...-$410,947K (-961.05%↓ Y/Y)Net cash used inoperating activities-$33,145K (24.69%↑ Y/Y)Canceled cashflow$79,600K Canceled cashflow$16,826K Purchases of marketablesecurities$490,547K (222.12%↑ Y/Y)Net loss-$41,206K (9.58%↑ Y/Y)Prepaid expenses andother current assets$4,643K (506.93%↑ Y/Y)Related party accountspayable and other...-$3,004K (49.11%↑ Y/Y)Net accretion ofpremiums and discounts on...$955K (-71.06%↓ Y/Y)Operating lease liability-$138K (-375.86%↓ Y/Y)Other non-currentassets$25K (-58.33%↓ Y/Y)

Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics, Inc. (ORKA)

Cash Flow
Quarterly Cash Flow Statement for the quarter ending in 2026-06-30
source: myfinsight.com